Clinton Group’s Innoviva INVA Stock Holding History

Clinton Group’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-16,782	Closed	-$180K	–	977
2016 Q4	$180K	Sell	16,782 -7,723	-32%	-$81.1K	0.01%	779
2016 Q3	$269K	Buy	+24,505	New	+$286K	0.01%	789

Other funds holding INVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Clinton Group's INVA Position: Q1 2017 in Review

Clinton Group sold out of Innoviva (INVA) in Q1 2017, closing a stake of 16,782 shares — an estimated $180K sold.

Clinton Group first reported a position in INVA in Q3 2016 and held it in 2 quarters. The position peaked at $269K in Q3 2016. 164 funds tracked by Wall St. Rank hold INVA as of Q1 2017.

Clinton Group reported no remaining Innoviva position as of Q1 2017 after selling out during the quarter.
Clinton Group sold 16,782 Innoviva shares in Q1 2017, an estimated $180K.
Clinton Group first reported a position in Innoviva in Q3 2016 and held it in 2 quarters.
Clinton Group's Innoviva position peaked at $269K in Q3 2016.
164 funds tracked by Wall St. Rank held Innoviva as of Q1 2017.

Based on Clinton Group's 13F filing for Q1 2017, filed 10 May 2017.